The American Association for Cancer Research (AACR) congratulates the four recipients of the inaugural NextGen Grants for Transformative Cancer Research.
The recipients were honored at the AACR Annual Meeting 2016, held April 16–20 in New Orleans.
“The AACR is very proud to announce the first recipients of the AACR-sponsored NextGen Grants for Transformative Cancer Research,” said AACR Past President Carlos L. Arteaga, MD. “These scientists clearly represent the brilliant young minds that we hoped to attract with this funding mechanism, and we are confident that their work will make important impacts in their fields.”
The 2016 recipients are:
2016 AACR NextGen Grant for Transformative Cancer Research
- Paul A. Northcott, PhD, St. Jude Children’s Research Hospital
“Integrative functional genomics of recurrent childhood medulloblastoma”
2016 AACR-Bayer NextGen Grant for Transformative Cancer Research
- Andrew Hsieh, MD, Fred Hutchinson Cancer Research Center
“The translation apparatus and mRNA dynamics in cancer”
2016 AACR-Incyte Corporation NextGen Grant for Transformative Cancer Research
- Sophia Y. Lunt, PhD, Michigan State University
“Deciphering metabolic rewiring in cancer”
2016 AACR-Takeda Oncology NextGen Grant for Transformative Cancer Research
- Nikil Wagle, MD, Dana-Farber Cancer Institute
“Overcoming resistance to combined ER and CDK4/6 inhibition in breast cancer”
The AACR NextGen Grants for Transformative Cancer Research will be offered again in 2017. The Call for Applications for these grants will open in 2016. For more information, please see the AACR Funding page (http://www.aacr.org/funding). ■
Paul A. Northcott, PhD
Andrew Hsieh, MD
Sophia Y. Lunt, PhD
Nikil Wagle, MD
